Parent Company Control and Conflicts of Interest with Public Shareholders
First written in FY2021. 5 of 7 entries say "Restated". Latest entry: 2026-06-25.
The whole theme swung hardest in 2025: 3 of 20 companies on the "Worse" side.
21 other companies' latest entry also says "Restated".
- 2026-06-25RestatedGovernance
「NIHON TRIM CO.,LTD. was listed on JASDAQ in 2000 and has been listed on the First Section of the Tokyo Stock Exchange, now the Prime Market, since March 2004. The group consists of seven consolidated subsidiaries, including us, and four equity-method affiliates.」
The company reaffirmed that NIHON TRIM CO.,LTD. is its parent company, with a 71.3% voting interest. It explained its independent decision-making and management independence by stating that there are no collaboration matters with the parent group and no matters requiring prior approval by the parent company. It also stated that the Company’s Representative Director and President changed to a part-time director of the parent company. - FY2026RestatedAnnual report
「We belong to the corporate group of NIHON TRIM CO.,LTD., a company listed on the Tokyo Stock Exchange's Prime Market, which is our parent company and holds 71.3% of our voting rights.」
The structure in which NIHON TRIM CO.,LTD. is the parent company and the possibility of influence over decision-making through its 71.3% voting interest continue to be described, along with Board of Directors review of related-party transactions. - FY2025ReframedAnnual report
「We belong to the corporate group of NIHON TRIM CO.,LTD., a company listed on the Tokyo Stock Exchange's Prime Market, which is our parent company and holds 70.5% of our voting rights.」
The former parent company, Trim Medical Holdings Co., Ltd., was absorbed into NIHON TRIM CO.,LTD. on 1 February 2025, and the parent company shown was changed to NIHON TRIM CO.,LTD. NIHON TRIM CO.,LTD. holds 70.5% of the voting rights, and the explanations of independent decision-making and related-party transaction management continue. - FY2023RestatedAnnual report
「We belong to the corporate group of NIHON TRIM CO.,LTD., a company listed on the Tokyo Stock Exchange's Prime Market, and Trim Medical Holdings Co., Ltd., a wholly owned subsidiary of NIHON TRIM CO.,LTD., is our parent company, holding 72.1% of our voting rights.」
The parent company's 72.1% voting interest and the possibility of influence over decision-making, together with the response through Board of Directors review of related-party transactions, continue to be maintained. - FY2022RestatedAnnual report
「We belong to the corporate group of NIHON TRIM CO.,LTD., a company listed on the Tokyo Stock Exchange's First Section, and Trim Medical Holdings Co., Ltd., a wholly owned subsidiary of NIHON TRIM CO.,LTD., is our parent company, holding 72.1% of our voting rights. We do not require the parent company's prior approval and make our own decisions regarding management policies, business policies and business development. However, because the parent company holds the right to make or veto decisions on fundamental matters as our largest shareholder, it may influence our decision-making.」
The parent company's 72.1% voting interest and the possibility of influence over decision-making are described, and the response through the Related-Party Transaction Management Regulations and Board of Directors review continues to be maintained. - FY2022-Q2RestatedAnnual report
「Trim Medical Holdings Co., Ltd. 3,717,800 72.57」
Trim Medical Holdings, the parent company, is described as a major shareholder holding 72.57%. Although the ownership ratio has changed from 75.0% as previously reported, the quarterly report contains no new explanation of the risk of conflicts of interest with the parent company. - FY2021First statedAnnual report
「Trim Medical Holdings Co., Ltd., our parent company, held 75.0% of our voting rights as of the date of filing and was a controlling shareholder and a wholly owned subsidiary of NIHON TRIM CO.,LTD. In light of the risk of conflicts of interest between the parent company and general shareholders in these circumstances, related-party transactions, including transactions involving conflicts of interest with the parent company's group companies, are subject to confirmation of their economic rationality and other factors and approval by the Board of Directors in accordance with the Related-Party Transaction Management Regulations.」
The voting interest is presented, together with management under the Related-Party Transaction Management Regulations and through Board of Directors approval.